1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
695B42877D9623A5985257FEE006FA6AE
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-role-medical-affairs-payer-interactions-training-segmentation-staffing?opendocument
18
19opendocument
2034.235.143.190
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Health Outcomes

The Role of Medical Affairs in Payer Interactions: Training, Segmentation, and Staffing

ID: 5422


Features:

19 Info Graphics

15 Data Graphics

280+ Metrics

5 Narratives


Pages/Slides: 43


Published: 2016


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "The Role of Medical Affairs in Payer Interactions: Training, Segmentation, and Staffing"

STUDY OVERVIEW

Payers drive so much revenue for pharmaceutical companies that the industry recognizes the importance of creating and maintaining effective relationships with the payer community. A key aspect of those relationships revolves around providing health outcomes information. The medical affairs function has long been involved in the dissemination of medical information to external stakeholders so, not surprisingly, many pharma companies have turned to this function to aid in payer interactions.

However, medical affairs organizations often face challenges in executing effective payer interactions and maintaining appropriately sized and trained field groups for payer engagement and market access activities.

Best Practices, LLC undertook this benchmarking study to understand the role of medical affairs in critical payer interactions and to highlight strategies for building and maintaining effective relationships with payers. In particular, this study provides benchmarks around payer segmentation and prioritization as well as the optimal field force levels, talent and training for ensuring effective payer relationships.

This study includes segments for large and small companies and US only and global.


KEY TOPICS

  • Talent Background and Training
  • Knowledge Sharing
  • Payer Segmentation and Prioritization
  • Medical Affairs and Payer Resource Ratios

KEY METRICS
  • Effectiveness of staff’s educational backgrounds for payer services
  • Effectiveness of staff’s experiences for payer services
  • Necessary qualifications for success in payer communication
  • Scope of training for Medical Affairs employees serving payers
  • Critical success factors for strong communication with payers
  • Knowledge sharing via an internal group
  • Collaboration of Medical Affairs group with supporting functions that directly interact with payers
  • Knowledge sharing channels and their effectiveness
  • Collaboration with field-based teams
  • Effectiveness of segmenting payers by listed criteria and strategies
  • Importance of different influencers/payers on market access
  • Medical Affairs spend as percentage of total revenue
  • Medical Affairs spend per Medical Affairs FTE
  • Payer staff as percentage of total Medical Affairs employees
SAMPLE KEY FINDINGS
  • Training the Talent: Scientific information and communicating real world data are among the top training areas for payer-oriented staff. While 67% of the participants design structured trainings on scientific information, 59% do so on translating real world evidence into effective messages.
  • Regardless of company size, training on scientific data, regulations and compliance are critical for pharma. However, larger companies have a more focus on training that brings a business approach into perspective. For example, training on communication and business understanding is as important for larger companies as training on scientific, regulatory and compliance information.

METHODOLOGY

This study reflects the data of 29 survey responses from Medical Affairs leaders at 27 biopharmaceutical companies.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Chemical; Health Care


Companies Profiled:
Abbvie; Alkermes; AstraZeneca; Baxalta; Biogen; CSL Behring; Daiichi Sankyo; EMD Serono; Genentech; Genomic Health; Lundbeck; Incyte; Janssen; Medivation; Mesoblast; Novartis; Pacira Pharmaceuticals; Pfizer; Pharmacyclics; ProStrakan; Santen; Servier; Shire; Teva Pharmaceutical Industries Ltd; Upsher-Smith; ViiV Healthcare


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.